Vedolizumab for Collagenous Colitis: Medical Necessity Assessment
Introduction to Vedolizumab
- Vedolizumab is FDA-approved for moderate to severe ulcerative colitis and Crohn's disease, but not for microscopic colitis subtypes including collagenous colitis 1, 2
- The British Society of Gastroenterology guidelines (2025) do not include vedolizumab as a recommended treatment for microscopic colitis subtypes 1, 2